Allegro Diagnostic to Launch Lung Cancer Test by 2011

Allegro Diagnostics, Inc.MBBP Client Allegro Diagnostics will begin marketing a “microarray-based test” for early-stage lung cancer. Allegro CEO Dan Rippy intends to offer a test called BronchoGen as a unique service through its clinical laboratory. BronchoGen is an 80-gene biomarker assay that can detect and rule out the presence of cancer cells. This screening will complement bronchoscopy, a procedure in which a clinician examines a patients airways with a scope in order to rule out the presence of cancer. Rippy hopes BronchoGen will be available by the end of 2010.

For the full article, please see GenomeWeb Daily News.

For more information on BronchoGen, please visit Allegro Diagnosics.

One thought on “Allegro Diagnostic to Launch Lung Cancer Test by 2011

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s